Lo Loestrin Fe FDA Approval History
FDA Approved: Yes (First approved October 21, 2010)
Brand name: Lo Loestrin Fe
Generic name: norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate
Dosage form: Tablets
Company: AbbVie Inc.
Treatment for: Birth Control
Lo Loestrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate) is an estrogen/progestin COC indicated for use by women to prevent pregnancy.
Development timeline for Lo Loestrin Fe
Date | Article |
---|---|
Oct 22, 2010 | Approval Warner Chilcott Announces FDA Approval of New Oral Contraceptive Lo Loestrin Fe |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.